Found 396 results
[ Author(Desc)] Keyword Title Type Year
Filters: First Letter Of Keyword is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Krueger SK, Henderson MC, Siddens LK, VanDyke JE, Benninghoff AD, P Karplus A, Furnes B, Schlenk D, Williams DE.  2009.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.. Drug Metab Dispos. 37(8):1785-91.
Krueger SK, Henderson MC, Siddens LK, VanDyke JE, Benninghoff AD, P Karplus A, Furnes B, Schlenk D, Williams DE.  2009.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.. Drug Metab Dispos. 37(8):1785-91.
Krueger SK, Williams DE, Yueh M-F, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR.  2002.  Genetic polymorphisms of flavin-containing monooxygenase (FMO).. Drug Metab Rev. 34(3):523-32.
Krueger SK, Henderson MC, Siddens LK, VanDyke JE, Benninghoff AD, P Karplus A, Furnes B, Schlenk D, Williams DE.  2009.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.. Drug Metab Dispos. 37(8):1785-91.
Kubglomsong S, Theerakulkait C, Reed RL, Yang L, Maier CS, Stevens JF.  2018.  Isolation and Identification of Tyrosinase-Inhibitory and Copper-Chelating Peptides from Hydrolyzed Rice-Bran-Derived Albumin.. J Agric Food Chem. 66(31):8346-8354.
Kubglomsong S, Theerakulkait C, Reed RL, Yang L, Maier CS, Stevens JF.  2018.  Isolation and Identification of Tyrosinase-Inhibitory and Copper-Chelating Peptides from Hydrolyzed Rice-Bran-Derived Albumin.. J Agric Food Chem. 66(31):8346-8354.
Kuschner CE, Choi J, Yin T, Shinozaki K, Becker LB, Lampe JW, Kim J.  2018.  Comparing phospholipid profiles of mitochondria and whole tissue: Higher PUFA content in mitochondria is driven by increased phosphatidylcholine unsaturation.. J Chromatogr B Analyt Technol Biomed Life Sci. 1093-1094:147-157.
Kuschner CE, Choi J, Yin T, Shinozaki K, Becker LB, Lampe JW, Kim J.  2018.  Comparing phospholipid profiles of mitochondria and whole tissue: Higher PUFA content in mitochondria is driven by increased phosphatidylcholine unsaturation.. J Chromatogr B Analyt Technol Biomed Life Sci. 1093-1094:147-157.
L
Lande C, Rao S, Morré JT, Galindo G, Kirby J, Reardon PN, Bobe G, Stevens JFrederik.  2019.  Linden (Tilia cordata) associated bumble bee mortality: Metabolomic analysis of nectar and bee muscle.. PLoS One. 14(7):e0218406.
Larsen CA, Dashwood RH.  2010.  (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.. Arch Biochem Biophys. 501(1):52-7.
Larsen CA, Bisson WH, Dashwood RH.  2009.  Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.. J Med Chem. 52(21):6543-5.
Larsen CA, Dashwood RH.  2009.  Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxide.. Biochem Biophys Res Commun. 389(3):527-30.
Larsen CA, Dashwood RH.  2010.  (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.. Arch Biochem Biophys. 501(1):52-7.
Larsen CA, Bisson WH, Dashwood RH.  2009.  Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.. J Med Chem. 52(21):6543-5.
Larsen CA, Dashwood RH.  2010.  (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.. Arch Biochem Biophys. 501(1):52-7.
Larsen CA, Bisson WH, Dashwood RH.  2009.  Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.. J Med Chem. 52(21):6543-5.
Larsen CA, Dashwood RH.  2010.  (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.. Arch Biochem Biophys. 501(1):52-7.
Larsen CA, Bisson WH, Dashwood RH.  2009.  Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.. J Med Chem. 52(21):6543-5.
Larsen CA, Dashwood RH.  2009.  Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxide.. Biochem Biophys Res Commun. 389(3):527-30.
Larsen-Su SA, Krueger SK, Yueh MFei, Pereira CB, Williams DE.  2002.  Developmental regulation of flavin-containing monooxygenase form 1 in the liver and kidney of fetal and neonatal rabbits.. Biochem Pharmacol. 63(7):1353-9.
Lebold KM, Traber MG.  2014.  Interactions between α-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis.. Free Radic Biol Med. 66:13-9.
Lee BY, Ordovás JM, Parks EJ, Anderson CAM, Barabási A-L, Clinton SK, de la Haye K, Duffy VB, Franks PW, Ginexi EM et al..  2022.  Research gaps and opportunities in precision nutrition: an NIH workshop report.. Am J Clin Nutr. 116(6):1877-1900.
Legette LC, Karnpracha C, Reed RL, Choi J, Bobe G, J Christensen M, Rodriguez-Proteau R, Purnell JQ, Stevens JF.  2014.  Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops.. Mol Nutr Food Res. 58(2):248-55.
Legette LCL, Luna AYMoreno, Reed RL, Miranda CL, Bobe G, Proteau RR, Stevens JF.  2013.  Xanthohumol lowers body weight and fasting plasma glucose in obese male Zucker fa/fa rats.. Phytochemistry. 91:236-41.
Legette LC, Ma L, Reed RL, Miranda CL, Christensen JMark, Rodriguez-Proteau R, Stevens JF.  2012.  Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration.. Mol Nutr Food Res. 56(3):466-74.

Pages